nnc 711 has been researched along with malonic acid in 2 studies
| Studies (nnc 711) | Trials (nnc 711) | Recent Studies (post-2010) (nnc 711) | Studies (malonic acid) | Trials (malonic acid) | Recent Studies (post-2010) (malonic acid) |
|---|---|---|---|---|---|
| 112 | 0 | 21 | 905 | 1 | 231 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, LP; Nicklas, WJ; Stokes, AH; Zeevalk, GD | 1 |
| Manzino, L; Sonsalla, PK; Zeevalk, GD | 1 |
2 other study(ies) available for nnc 711 and malonic acid
| Article | Year |
|---|---|
Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711.
Topics: Animals; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Malonates; Mesencephalon; Muscimol; Neurons; Nipecotic Acids; Oximes; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2001 |
Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
Topics: Animals; Carrier Proteins; Catheterization; Corpus Striatum; Dopamine; Drug Administration Routes; GABA Agonists; GABA Antagonists; GABA Plasma Membrane Transport Proteins; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Malonates; Membrane Proteins; Membrane Transport Proteins; Neuroprotective Agents; Nipecotic Acids; Organic Anion Transporters; Oximes; Rats; Rats, Sprague-Dawley | 2002 |